The antidepressant efficacy of agomelatine in daily practice : interim-analysis of the non-interventional study VIVALDI

被引：0
|
作者：
Laux, G. [1 ]
Steinmann, C. [1 ]
机构：
[1] Inn Salzach Klinikum, Wasserburg, Germany
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [21] Efficacy of bortezomib under routine conditions. Interim results of a prospective, non-interventional study
    Overkamp, F.
    Wolf, H.
    Seipelt, G.
    Gaska, T.
    Hurtz, H.
    Kornacker, M.
    ONKOLOGIE, 2008, 31 : 125 - 125
  • [22] PREDICT (Patient characteristics in Renal cell carcinoma and Daily practice Treatment with Nexavar) global non-interventional study: first interim results
    Jager, D.
    Ma, J. H.
    Korbenfeld, E.
    Zemanova, M.
    Leonhartsberger, N.
    Stauch, K.
    Boeckenhoff, A.
    Yu, J.
    Escudier, B.
    EJC SUPPLEMENTS, 2009, 7 (02): : 431 - 432
  • [23] The Use of a Self-Occluding Topical Anasthetic in Daily Practice: A Non-Interventional Study
    Jain, Ravi
    Arias, Gerardo Moreno
    Naranjo, Pablo
    Murison, Max
    Lopez Estebaranz, Jose Luis
    Fratila, Alma
    Prager, Welf
    Guillen Barona, Carlos
    Weidmann, Michael
    Dahan, Serge
    Cartier, Hugues
    Sattler, Gerhard
    Podda, Maurizio
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (04) : 413 - 418
  • [24] Agomelatine in real-life. Efficacy, tolerability and impact on anhedonia: a pooled analysis of 8 non-interventional studies
    Di Giannantonio, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S859 - S859
  • [25] TOCILIZUMAB IN RHEUMATOID ARTHRITIS - ANNUAL INTERIM ANALYSIS OF THE GERMAN NON-INTERVENTIONAL STUDY ICHIBAN
    Specker, C.
    Kaufmann, J.
    Kellner, H.
    Bohl-Buehler, M.
    Schwenke, H.
    Vollmer, M. A.
    Kapelle, A.
    Zinke, S.
    Hofmann, M. W.
    Hellmann, P.
    Fliedner, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 879 - 879
  • [26] Efficacy and Tolerability of Certolizumab pegol for the Treatment of rheumatoid Arthritis in clinical Practice in Germany: 3rd Interim Analysis of non-interventional Study "Fast"
    Burmester, G.
    Mueller-Ladner, U.
    Nuesslein, H.
    von Hinueber, U.
    Edelmann, E.
    Detert, J.
    Hoehle, M.
    Richter, C.
    Klopsch, T.
    Kumke, T.
    Fricke, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 100 - 100
  • [27] Tocilizumab, DMARDs and Glucocorticoide in rheumatoid Arthritis - Interim Analysis of the non-interventional ICHIBAN Study
    Specker, C.
    Kaufmann, J.
    Kellner, H.
    Bohl-Buehler, M.
    Schwenke, H.
    Vollmer, M.
    Kapelle, A.
    Zinke, S.
    Hofmann, M.
    Hellmann, P.
    Fliedner, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 114 - 114
  • [28] 2016 Interim analysis of the prospective, non-interventional study JAKoMo: new insights into ruxolitinib treatment of myelofibrosis in daily clinical routine
    Geer, T.
    Heinrich, B.
    Jacobasch, L.
    Tesch, H.
    Wehmeyer, J.
    Schlag, R.
    Groeschl, B.
    Markhauser, M.
    Bachhuber, P.
    Koschmieder, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 149 - 149
  • [29] Tolerability and efficacy of the intravenous immunoglobulins octagam® 5% and octagam® 10% in secondary immunodeficiencies - Interim analysis of a non-interventional study
    Tschechne, B.
    Jansen, M.
    Klein, I
    Lietz, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 297 - 297
  • [30] Evolocumab in clinical Practice in Austria: 6 Months Interim Data on Patient Characteristics, Efficacy and Tolerability from a European, non-interventional Study
    Drexel, Heinz
    Toplak, Hermann
    Hanusch, Ursula
    Prager, Rudolf
    Sourij, Harald
    Hemetsberger, Margit
    Ratzinger, Michaela
    Ebenbichler, Christoph
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 359 - 360
12345